Active Psoriatic Arthritis
PMG Research of Salisbury
18 or older
A research study is evaluating an investigational medication for adults with active psoriatic arthritis.
This research study may be an option if you:
• Have had a diagnosis of psoriatic arthritis for at least six months
• Have at least one lesion of plaque psoriasis
• Have no prior exposure to OR have not responded to biologic treatment such as Enbrel®, Humira®, or Remicade®
Other criteria apply. Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you.
*An optional 36 weeks of participation including 10 additional clinic visits will be evaluating the investigational medication compared to an FDA-approved medication.
Qualified participants will receive all study-related care and study medication at no cost.
Patient Commitment Duration
Approximately 5 months (*Optional 36 weeks of additional treatment)
Financial compensation may be provided for travel and parking expenses.
Number of visits in study
Approximately 9 clinic visits (*Optional 10 additional clinical visits)